Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-ku, Sapporo, 060-8543, Japan.
Clin Exp Nephrol. 2021 Jul;25(7):708-717. doi: 10.1007/s10157-021-02048-1. Epub 2021 Mar 16.
The risk of contrast-induced nephropathy (CIN) is high in patients with chronic kidney disease (CKD). However, the mechanism of CIN in CKD is not fully understood. Here, we prepared a clinically relevant model of CIN and examined the role of necroptosis, which potentially cross-talks with autophagy, in CIN.
In Sprague-Dawley rats, CKD was induced by subtotal nephrectomy (SNx, 5/6 nephrectomy) 4 weeks before induction of CIN. CIN was induced by administration of a contrast medium (CM), iohexol, following administration of indomethacin and N-omega-Nitro-L-arginine methyl ester. Renal function and tissue injuries were assessed 48 h after CM injection.
Serum creatinine (s-Cre) and BUN were increased from 0.28 ± 0.01 to 0.52 ± 0.02 mg/dl and from 15.1 ± 0.7 to 29.2 ± 1.2 mg/dl, respectively, after SNx alone. CM further increased s-Cre and BUN to 0.69 ± 0.03 and 37.2 ± 2.1, respectively. In the renal tissue after CM injection, protein levels of receptor-interacting serine/threonine-protein kinase (RIP) 1, RIP3, cleaved caspase 3, and caspase 8 were increased by 64 ~ 212%, while there was reduction in LC3-II and accumulation of p62. Necrostatin-1, an RIP1 inhibitor, administered before and 24 h after CM injection significantly suppressed elevation of s-Cre, BUN and urinary albumin levels, kidney injury molecule-1 expression and infiltration of CD68-positive macrophages in renal tissues after CM injection.
The results suggest that necroptosis of proximal tubular cells contributes to CIN in CKD and that suppression of protective autophagy by pro-necroptotic signaling may also be involved.
患有慢性肾病(CKD)的患者发生造影剂诱导的肾病(CIN)的风险很高。然而,CKD 中 CIN 的机制尚未完全阐明。在这里,我们制备了一种临床相关的 CIN 模型,并研究了潜在与自噬相互作用的坏死性凋亡在 CIN 中的作用。
在 Sprague-Dawley 大鼠中,在诱导 CIN 前 4 周通过 5/6 肾切除术(SNx)诱导 CKD。在给予吲哚美辛和 Nω-硝基-L-精氨酸甲酯后,给予造影剂(碘海醇)诱导 CIN。在 CM 注射后 48 小时评估肾功能和组织损伤。
SNx 单独治疗后,血清肌酐(s-Cre)和 BUN 从 0.28±0.01mg/dl 增加到 0.52±0.02mg/dl 和 15.1±0.7mg/dl 增加到 29.2±1.2mg/dl。CM 进一步将 s-Cre 和 BUN 增加到 0.69±0.03mg/dl 和 37.2±2.1mg/dl。在 CM 注射后的肾组织中,受体相互作用丝氨酸/苏氨酸蛋白激酶(RIP)1、RIP3、裂解的半胱天冬酶 3 和半胱天冬酶 8 的蛋白水平增加了 64%至 212%,而 LC3-II 减少,p62 积累。在 CM 注射前和注射后 24 小时给予 RIP1 抑制剂 Necrostatin-1,可显著抑制 CM 注射后 s-Cre、BUN 和尿白蛋白水平的升高,肾损伤分子-1 表达和 CD68 阳性巨噬细胞在肾组织中的浸润。
结果表明,近端肾小管细胞的坏死性凋亡导致 CKD 中的 CIN,并且促坏死性凋亡信号对保护性自噬的抑制也可能参与其中。